Aevi Genomic Medicine Inc (GNMX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

435 DEVON PARK DRIVE, WAYNE, PA 19087

Medgenics, Inc., a commercial-stage biopharmaceutical company, focuses on providing protein therapies. The company develops the Biopump Platform, a proprietary technology, which uses the patients own tissue to continuously produce and deliver the patients own protein therapy. It is designed to provide protein therapy to treat a range of chronic diseases, including anemia, hepatitis C, hemophilia, multiple sclerosis, arthritis, pediatric growth hormone deficiency, obesity, diabetes, and other chronic diseases or conditions. The companys product line includes EPODURE, a Biopump producing erythropoietin in Phase I/II clinical trial to treat anemia in patients with chronic kidney disease; INFRADURE, a Biopump producing interferon-alpha in preclinical stage for the treatment of hepatitis-C; and HEMODURE, a Biopump to produce clotting Factor VIII for the treatment of hemophilia. Medgenics, Inc. was founded in 2000 and is based in San Francisco, California.

Data based on most recent fiscal year report
Market Cap110.354 Million Shares Outstanding59.33 Million Avg Volume647.975 Thousand
1-Yr BETA vs S&P TR1.171 Current Ratio8.36 Quick Ratio8.36
View SEC Filings from GNMX instead.
Q2 2019 All Institutions Hedge Funds 1
To trade GNMX now:
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 30 3 (0.31%)
Aggregate 13F shares on 06/30/2019: 4.717 Million 2.098 Million
Aggregate 13F shares on 03/31/2019: 4.112 Million 1.286 Million
Percent change: 14.71% 63.12%
Funds creating new positions: 5
Funds Adding to an existing position: 4 1
Funds closing out their position: 3
Funds reducing their position: 7 1
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding GNMX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

COLA MICHAEL F

  • Director
0 2019-10-24 0

GANTZ WILBUR H

  • Director
0 2019-09-30 0

BAUER EUGENE A CHIEF MEDICAL OFFICER

42,307 2019-08-15 0

BARER SOL J

  • Director
0 2019-08-13 0

DUNCAN BARBARA GAYLE

  • Director
0 2019-07-02 0

NEIL GARRY ARTHUR

  • Director
5,704 2019-06-13 0

MCINAW MICHAEL INTERIM CFO

  • Officer
16,107 2019-06-01 1

BLECH ISAAC

  • Director
0 2019-05-07 0

CHILDREN'S HOSPITAL OF PHILADELPHIA FOUNDATION

  • 10% Owner
1,954,957 2019-02-27 0

GRANO JOSEPH J JR

  • Director
174,847 2018-11-07 0

LEAMAN JOHN HAROLD CFO, TREAS. & HD CORP STRATEGY

  • Officer
0 2018-06-15 0

CLEMOW ALASTAIR J

  • Director
0 2018-06-14 0

PIPER BRIAN CFO & CORPORATE SECRETARY

  • Officer
0 2018-06-14 0

BAYLEY MATTHEW D

  • Director
0 2018-06-14 0

KANTER JOEL S

339,424 2017-11-12 0

HARPER PHILIP R

  • 10% Owner
5,179,819 2017-09-01 0

APPLEBAUM SCOTT GENERAL COUNSEL

  • Officer
No longer subject to file 2016-10-25 0

MCMURRAY STEPHEN D

  • Director
0 2015-02-18 0

BLECH ISAAC

LIBERTY CHARITABLE REMAINDER TRUST F/B/O ISAAC BLECH

RIVER CHARITABLE REMAINDER UNITRUST F/B/O ISAAC BLECH

WEST CHARITABLE REMAINDER UNITRUST

  • 10% Owner
233,571,430 2013-05-02 0

PEARLMAN ANDREW PRESIDENT AND CEO

  • Officer
  • Director
0 2011-09-22 0

BRUKARDT GARY A

  • Director
66,077 2011-09-07 0

DELLIO CLARENCE L CHIEF OPERATING OFFICER

  • Officer
0 2011-07-01 0

STERN BARUCH CHIEF SCIENTIFIC OFFICER

  • Officer
29,726 2011-05-11 0

ESTATE OF LORD LEONARD STEINBERG

  • 10% Owner
606,555 2011-04-13 0

KANTER JOSHUA

  • 10% Owner
636,975 2011-04-13 0

CHICAGO INVESTMENTS INC

  • 10% Owner
636,975 2011-04-13 0

RIVER CHARITABLE REMAINDER UNITRUST F/B/O ISAAC BLECH

  • 10% Owner
0 2011-04-07 0

BELLIN PHYLLIS K. SEE REMARKS

  • Officer
10,664 2011-04-07 0

BELLOMO STEPHEN CHIEF OPERATING OFFICER

  • Officer
0 2011-04-07 0

RIVER CHARITABLE REMAINDER UNITRUST F/B/O ISAAC BLECH

BLECH ISAAC

  • 10% Owner
0 2011-04-07 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments